news

한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina

As of 09:36 on August 19, 2024, the CSI A50 Index (930050) rose by 0.94%, and the A50ETF Fund (159592) rose by 0.84%, hitting a three-day winning streak. The latest price was 0.96 yuan, and the intraday turnover reached 11.1888 million yuan, temporarily ranking 3/10 of comparable ETFs, with a turnover rate of 0.27%. Constituent stocks CRRC Corporation Limited (601766) rose by 4.59%, Zhifei Biopharmaceuticals (300122) rose by 3.50%, and CATL, Mindray Medical and Zijin Mining followed suit.

Data shows that the latest scale of A50ETF Fund (159592) has reached 4.198 billion yuan, a new high since its establishment, ranking 2/10 of comparable funds; there have been net inflows of funds on 4 of the past 5 trading days, with a total of 71.5044 million yuan, and the average daily net inflow reached 14.3009 million yuan.

The A50ETF Fund (159592) closely tracks the CSI A50 Index, which selects the 50 securities with the largest market capitalization from the leading listed securities in various industries as index samples to reflect the overall performance of the most representative leading listed securities in various industries.

It is worth noting that the valuation of the CSI A50 Index tracked by the fund is at a historical low, with the latest price-to-book ratio (PB) being 1.83 times, which is lower than the index for more than 90% of the time in the past year, and the valuation has outstanding cost-effectiveness.